Company intelligence / Profile preview

FDC

Ownership: Public · FDC
Development stage: Other

Overview

FDC has a broad commercial portfolio across 14 therapeutic segments with strong brands in anti-infectives (~42% of revenue) and gastrointestinal drugs (~24%). The company also has preclinical/early-stage R&D in biologics including recombinant proteins such as G-CSF and novel thrombolytics. Recent clinical progress includes completion of preclinical studies for new chemical entities and permission to approach Indian regulators for human trials[5]. In 2025 the company recalled a batch of timolol maleate ophthalmic solution in the US due to a packaging defect[6].

Therapeutic areas: Metabolic DisordersDermatologyGastroenterologyCardiovascularOphthalmologyInfectious Diseases
Modalities: Small moleculeRecombinant proteinBiologic
Industry: Biotech

Partnerships

Fair Deal Corporation Pharmaceutical SA(Pty) Ltd.Technology licensing agreements for certain biologics projects

Financials

Market cap: $37.4M
Total revenue: $0
Enterprise value: $31.8M

Beyond the preview

Go deeper on FDC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FDC.

Explore the full profile